These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 3939121)
21. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin. Chau PY; Ling J; Ng WS J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100 [TBL] [Abstract][Full Text] [Related]
22. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem. Van der Auwera P; Husson M; Bulliard G Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194 [TBL] [Abstract][Full Text] [Related]
23. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents. Davidson S; Lipshitz M; Bogokowski B; Rubinstein E Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501 [TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents. Ishag AJ; Durgham SM; Shibl AM Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333 [TBL] [Abstract][Full Text] [Related]
25. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa]. Schröter G; Schrettenbrunner A Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589 [No Abstract] [Full Text] [Related]
26. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ]. Thabaut A; Durosoir JL; Meyran M Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006 [TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Weinstein RA; Nathan C; Delzell D; Kabins SA Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens. Meyer RD; Pasiecznik K Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092 [TBL] [Abstract][Full Text] [Related]
29. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa]. Cluzel M; Chanal M; Sirot J; Cluzel R Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523 [TBL] [Abstract][Full Text] [Related]
30. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa]. Thabaut A; Meyran M Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428 [TBL] [Abstract][Full Text] [Related]
31. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli. Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792 [TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates. Bastianini L; Sposini T; Bartoli A; Marconi P Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli. Bujdáková H; Kallová J; Lausová A; Kettner M Microbios; 1995; 84(339):87-90. PubMed ID: 8628124 [TBL] [Abstract][Full Text] [Related]
35. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Brown JE; Del Bene VE; Collins CD Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986 [TBL] [Abstract][Full Text] [Related]
37. [In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D]. Zuccarelli M; Attisso MA; Simeon de Buochberg M; Dusart G Pathol Biol (Paris); 1987 May; 35(5):581-5. PubMed ID: 3112710 [TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin. Dibb WL; Asphaug Kjellevold V; Digranes A Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491 [TBL] [Abstract][Full Text] [Related]
39. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin]. Bartmann K; Tarbuc R Infection; 1982; 10(6):361-70. PubMed ID: 6818153 [TBL] [Abstract][Full Text] [Related]
40. [The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics]. Sener B; Hayran M; Kocagöz T; Ustaçelebi S Mikrobiyol Bul; 1990 Apr; 24(2):120-5. PubMed ID: 2128529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]